Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis

Clinical trial NCT03889639 · COMPLETED

Trial details

NCT number: NCT03889639
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis

Start date: 2019-03-29
Primary completion: 2020-01-02
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.